We analyzed the basal mRNA expression of 27 breast cancer cell lines, previously characterized as sensitive or resistant to BYL719 (Elkabets et al., 2013), and found that resistant cell lines had significantly higher levels of SGK1 mRNA compared with sensitive cells (Figures 3A and S4A). This evidence concerns the gene SGK1 and breast cancer.